前往化源商城

European Journal of Pharmaceutics and Biopharmaceutics 2007-06-01

Poly(2-hydroxy-3-phenoxypropylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membrane controlled clonidine zero-order release.

Xiaoping Zhan, Sijing Chen, Guochun Tang, Zhenmin Mao

文献索引:Eur. J. Pharm. Biopharm. 66(3) , 429-34, (2007)

全文:HTML全文

摘要

Poly(2-hydroxy-3-phenoxypropylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membrane was synthesized by UV curing method in our laboratory for the first time. When above-mentioned monomers were in the weight ratio of 4:4:2, the membrane not only had perfect permeation property but also had excellent plasticity, so the membrane made from monomers in the ratio of 4:4:2 was chosen as an optimized membrane. The optimized membrane provided perfect linear permeation properties in clonidine transdermal drug delivery system. The permeation rate decreased in proportion to the thickness of membrane. When the concentrations of clonidine were in the range of 0.5-7.0mg/ml, the permeation rate was proportional to the square root of clonidine concentrations. The optimized membrane was characterized by FTIR, DSC and SEM.

相关化合物

结构式 名称/CAS号 全部文献
马来酸二丁酯 结构式 马来酸二丁酯
CAS:105-76-0
丙烯酸4-羟基丁酯 结构式 丙烯酸4-羟基丁酯
CAS:2478-10-6